Search
Showing results for "autism"
An interventional birth cohort researching ways to optimise health and identify conditions that enable every child to flourish from an early age.
Research
Exploring local government areas with significant shifts in child development between 2009 and 2012 on the Australian Early Development CensusThis project analysed AEDC results across Australia, to identify communities with significant improvement (decreases in developmental vulnerability) between 2009 and 2012
Research
Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposityThis paper examined the link between low serum Vitamin D levels and development of non-alcoholic fatty liver disease (NAFLD) in adolescents between 14 and 17...
An outline of ORIGINS sub-projects by name
We identify, develop and commercialise the technologies and innovations developed by our scientists and clinicians.
Research
Factors influencing participation in home, school, and community settings by children and adolescents with neuromuscular disorders: A qualitative descriptive studyThis study explored how children and adolescents with a neuromuscular disorder (NMD) and their parents experienced barriers and enablers to the child's participation.
News & Events
Sun safe: balancing the risks and benefitsThe D-Light program, set up in 2014, aims to shed light on the amount of sun exposure that will promote good health in children and adolescents.
Research
Energy drink consumption among young Australian adults: Associations with alcohol and illicit drug useAustralian energy drink users tend to have heavier alcohol consumption patterns be a cigarette smoker and use illicit drugs relative to non-users.
Research
Heavy prenatal alcohol exposure and increased risk of stillbirthThe objective was to investigate the association between heavy prenatal alcohol exposure and stillbirth.
Research
Predominance of nontypeable haemophilus influenzae in children with otitis mediaIn Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.